Journal of Lipid and Atherosclerosis (지질동맥경화학회지)

The Korean Society of Lipid and Atherosclerosis (한국지질동맥경화학회)
권호 표지

Increased Serum Ferritin Concentration is Associated with Increased Arterial Stiffness Assessed by Pulse Wave Velocity

혈청 페리틴 농도와 동맥 경직도의 상관관계

Lee, Min-Su;Park, Hyeong-Seo;Park, Jae-Hyeong;Lee, Jae-Hwan;Choi, Si-Wan;Jeong, Jin-Ok;Ku, Bon-Jeong;Kim, Dae-Hyun;Kim, Jei;Lee, Tae-Yong;Seong, In-Whan
이민수;박형서;박재형;이재환;최시완;정진옥;구본정;김대현;김제;이태용;성인환

  • Published : 20061200

⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Sullivan JL. Iron and the sex difference in heart disease risk. Lancet 1981;1(8233):1293-1294
  2. Sullivan JL. Stored iron and ischemic heart disease. Empirical support for a new paradigm. Circulation 1992;86(3):1036-1037 https://doi.org/10.1161/01.CIR.86.3.1036
  3. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992;86(3):803-811 https://doi.org/10.1161/01.CIR.86.3.803
  4. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 1997;96 (10):3300-3307 https://doi.org/10.1161/01.CIR.96.10.3300
  5. Lee TS, Shiao MS, Pan CC, Chau LY. Iron -deficient diet reduces atherosclerotic lesions in apoE-deficient mice. Circulation 1999;99(9): 1222-1229 https://doi.org/10.1161/01.CIR.99.9.1222
  6. de Valk B, Marx JJ. Iron, atherosclerosis, and ischemic heart disease. Arch Intern Med 1999; 159(14):1542-1548 https://doi.org/10.1001/archinte.159.14.1542
  7. Tsomi K, Karagiorga-Lagana M, Fragodimitri C, Karabatsos F, Katsiki V. Arterial elastorrhexis: manifestation of a generalized elastic tissue disorder in beta-thalassaemia major. Eur J Haematol 1999;63(5):287-294 https://doi.org/10.1111/j.1600-0609.1999.tb01130.x
  8. Slotwiner DJ, Devereux RB, Schwartz JE, Pickering TG, de Simone G, Ganau A, Saba PS, Roman MJ. Relation of age to left ventricular function in clinically normal adults. Am J Cardiol 1998;82(5):621-626 https://doi.org/10.1016/S0002-9149(98)00390-7
  9. Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999;33(5):1111-1117 https://doi.org/10.1161/01.HYP.33.5.1111
  10. Grundy SM, Pasternak R, Greenland P, Smith S, Jr., Fuster V. AHA/ACC scientific statement: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 1999;34(4):1348-1359 https://doi.org/10.1016/S0735-1097(99)00387-3
  11. Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K, Koji Y, Hori S, Yamamoto Y. Validity, reproducibility, and clinical significance of noninvasive brachial -ankle pulse wave velocity measurement. Hypertens Res 2002;25(3):359-364 https://doi.org/10.1291/hypres.25.359
  12. Oliver JJ, Webb DJ. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol 2003;23 (4):554-566 https://doi.org/10.1161/01.ATV.0000060460.52916.D6
  13. Vaitkevicius PV, Fleg JL, Engel JH, O'Connor FC, Wright JG, Lakatta LE, Yin FC, Lakatta EG. Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation 1993;88(4 Pt 1):1456-1462 https://doi.org/10.1161/01.CIR.88.4.1456
  14. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001;37(5): 1236-1241 https://doi.org/10.1161/01.HYP.37.5.1236
  15. Lehmann ED, Watts GF, Gosling RG. Aortic distensibility and hypercholesterolaemia. Lancet 1992;340(8828):1171-1172
  16. Lehmann ED, Gosling RG, Sonksen PH. Arterial wall compliance in diabetes. Diabet Med 1992;9(2):114-119 https://doi.org/10.1111/j.1464-5491.1992.tb01746.x
  17. Tuomainen TP, Punnonen K, Nyyssonen K, Salonen JT. Association between body iron stores and the risk of acute myocardial infarction in men. Circulation 1998;97(15):1461 -1466 https://doi.org/10.1161/01.CIR.97.15.1461
  18. Salonen JT, Nyyssonen K, Salonen R. Body iron stores and the risk of coronary heart disease. N Engl J Med 1994;331(17):1159; author reply 1160 https://doi.org/10.1056/NEJM199410273311714
  19. Cook JD, Flowers CH, Skikne BS. The quantitative assessment of body iron. Blood 2003;101(9):3359-3364 https://doi.org/10.1182/blood-2002-10-3071
  20. Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997;89(3):1052-1057
  21. Magnusson MK, Sigfusson N, Sigvaldason H, Johannesson GM, Magnusson S, Thorgeirsson G. Low iron-binding capacity as a risk factor for myocardial infarction. Circulation 1994;89 (1):102-108 https://doi.org/10.1161/01.CIR.89.1.102
  22. Manttari M, Manninen V, Huttunen JK, Palosuo T, Ehnholm C, Heinonen OP, Frick MH. Serum ferritin and ceruloplasmin as coronary risk factors. Eur Heart J 1994;15(12):1599-1603 https://doi.org/10.1093/oxfordjournals.eurheartj.a060440
  23. Danesh J, Appleby P. Coronary heart disease and iron status: meta-analyses of prospective studies. Circulation 1999;99(7):852-854 https://doi.org/10.1161/01.CIR.99.7.852
  24. Sempos CT, Looker AC, Gillum RE, McGee DL, Vuong CV, Johnson CL. Serum ferritin and death from all causes and cardiovascular disease: the NHANES II Mortality Study. National Health and Nutrition Examination Study. Ann Epidemiol 2000;10(7):441-448 https://doi.org/10.1016/S1047-2797(00)00068-5
  25. Hanson EH, Imperatore G, Burke W. HFEgene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology. Am J Epidemiol 2001;154(3):193-206 https://doi.org/10.1093/aje/154.3.193
  26. Myers CL, Weiss SJ, Kirsh MM, Shlafer M. Involvement of hydrogen peroxide and hydroxyl radical in the 'oxygen paradox': reduction of creatine kinase release by catalase, allopurinol or deferoxamine, but not by superoxide dismutase. J Mol Cell Cardiol 1985;17(7):675-684 https://doi.org/10.1016/S0022-2828(85)80067-5
  27. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320(14): 915-924 https://doi.org/10.1056/NEJM198904063201407
  28. Bolli R, Patel BS, Zhu WX, O'Neill PG, Hartley CJ, Charlat ML, Roberts R. The iron chelator desferrioxamine attenuates postischemic ventricular dysfunction. Am J Physiol 1987; 253(6 Pt 2):H1372-1380
  29. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991;88(6):1785-1792 https://doi.org/10.1172/JCI115499
  30. Aessopos A, Samarkos M, Voskaridou E, Papaioannou D, Tsironi M, Kavouklis E, Vaiopoulos G, Stamatelos G, Loukopoulos D. Arterial calcifications in beta-thalassemia. Angiology 1998;49(2):137-143 https://doi.org/10.1177/000331979804900206